Christine Lising, Director of Solutions Engineering, Americas at Shiji Group, discusses how empathy-driven design and AI innovation are enhancing efficiency, service quality, and guest experiences across hotel F&B operations. Technology continues to transform the hospitality industry-but how can innovation enhance, rather than replace, the human touch? In a new interview, Christine Lising, Director of Solutions […]

Lucky Energy, one of the fastest-growing energy beverage brands in the U.S., announced today that it has successfully closed an oversubscribed $25 million Series B funding round, led by Paine Schwartz Partners. The round also saw continued support from existing investors, along with new backers including North Fifth Services, LLC, Sequel, and Joyance Partners, among

NEW YORK, NY / ACCESS Newswire / November 12, 2025 / If you suffered a loss on your RCI Hospitality Holdings, Inc. (NASDAQ:RICK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rci-hospitality-holdings-inc-lawsuit-submission-form?prid=176894&wire=1&utm_campaign=31 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

NEW YORK, NY / ACCESS Newswire / November 12, 2025 / If you suffered a loss on your Fortinet, Inc. (NASDAQ:FTNT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fortinet-inc-lawsuit-submission-form?prid=176893&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

(NASDAQ:IMA), $142.6 million cash and cash equivalents and marketable securities as of September 30, 2025 Protocol amendment for ongoing Phase 2b ADAPTIVE study of IMG-007 in atopic dermatitis (AD) announced to optimize study design in alignment with IMG-007's unique molecular attributes; strong patient enrollment continues Novel alopecia areata data including biomarkers from Phase 1b/2a study

Biohaven Ltd.(NYSE: BHVN), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases, today announced the pricing of its underwritten public offering of 23,333,334 of its common shares at a price to the public of $7.50 per share. In addition,

Reports 19% Year-Over-Year Revenue Growth While Advancing Strategic Partnership Discussions to Enable Capital-Efficient Expansion and Enhanced Returns Reduced Year-to-Date Annualized Expenses by Nearly $8 million, with Additional Reduction of $1.5-2 Million Expected to be Actioned in the Fourth Quarter of 2025 Local Bounti Corporation (NYSE: LOCL) (“Local Bounti” or the “Company”), a breakthrough U.S. indoor

TransDigm Group Incorporated (NYSE: TDG), a leading global designer, producer and supplier of highly engineered aircraft components, today reported results for the fourth quarter ended September 30, 2025. https://mma.prnewswire.com/media/835315/TransDigm_Logo.jpg Fourth quarter highlights include: — Net sales of $2,437 million, up 12% from $2,185 million in the prior year's quarter; — Net income of $609 million,

ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team GlobeNewswire November 12, 2025 $142.6 million cash and cash equivalents and marketable securities as of September 30, 2025 Protocol amendment for ongoing Phase 2b ADAPTIVE study of IMG-007 in atopic dermatitis

Historian and philanthropist George McCully has published “Christianity Then and Now: Can it Be Saved?” presenting an authoritative definition of Christianity based on a new analysis of John's Gospel and later leaders, concluding with an original history of secularization and a proposed strategy of updates needed today for recovery from fatal subversion by secularity. https://mma.prnewswire.com/media/2820181/AuthorHouse_CHRISTIANITY_THEN_and_NOW.jpg